Home › Drug Codes › J Codes › J7213 · IXINITY
Updated October 1st, 2026

IXINITY J Code: J7213

Injection, coagulation factor ix (recombinant), ixinity, 1 i.u.

Login to unlock all benchmarks
Medicare Payment Limit ?
$2.035
/ HCPCS billing unit
APC Payment Limit ?
$2.035
/ HCPCS billing unit · APC 9146
ASP ?
$•••.••
Login to view
WAC · AWP ?
$•••.••
Login to view
NDCs Crosswalked ?
10
View NDC crosswalk →

Drug & Product Overview

HCPCS Descriptor Injection, coagulation factor ix (recombinant), ixinity, 1 i.u.
HCPCS Added Date July 1, 2023
Manufacturer Aptevo BioTherapeutics
Route of Administration Intravenous
Generic Status Single-Source; Branded
Dosage Type Single-Dose
Dosage Form Kit | Not Available

About IXINITY

Ixinity is a medication aligned to the HCPCS J Code: J7213 for billing, pricing, and reimbursement purposes in the United States. It is a Hematology drug administered via the intravenous route and manufactured by Aptevo BioTherapeutics.

According to CMS Drug Use Information: This medication is used to prevent or control bleeding in people with little or no factor IX (due to hemophilia B, Christmas disease). Factor IX is a protein (clotting factor) in the blood that works with other clotting factors to help the blood clot and stop bleeding. People with little or no factor IX are at risk for bleeding longer after an injury/surgery or bleeding suddenly (often in the joints/muscle) without an obvious cause. This medication should not be used to treat other types of factor deficiencies (such as factors II, VII, VIII, X) or factor problems (such as inhibitor to factor XIII), to reverse the effects of "blood thinners" (such as warfarin), or to treat bleeding from low levels of liver-dependent clotting factors (due to liver problems).

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

Based on publicly available CMS files. Showing 4 of 10 NDCs — log in for the full crosswalk.

Login to view 6 more NDC packages View pricing, complete NDC-to-HCPCS alignments, and package details.
Login →

IXINITY Pricing & Reimbursement

J7213 Private Payer Reimbursement
$2.05 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →
UnitedHealthcare, BlueCross BlueShield, Aetna, Cigna

Historical Graphing and Billing Calculator

per HCPCS unit
As of Q4 2026

Coagulation Factor Ix 505(b)(2) Information:

HCPCS Code Manufacturer Active Ingredient HCPCS Description
J7213 Generic Code (Multiple Manufacturers) Coagulation Factor Ix Injection, coagulation factor ix (recombinant), ixinity, 1 i.u.

IXINITY CPT Administration Codes

The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.

CPT Code Description
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure)
JW / JZ modifiers apply

CMS has identified Ixinity (J7213) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. Wastage billing guide →

IXINITY Medically Unlikely Edits (MUE)

The most billing units of J7213 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 1 iu.

Practitioner Office & Hospital Outpatient
12,000 units / day
= 12,000 iu per day

MAI 1 · Line Edit. Per-line limit: units are checked per claim line; medically necessary units beyond the limit may be billable on separate lines with appropriate modifiers. See all MUE limits →

iu Enter a dose to see how many billing units it is and whether it is under the limit.

IXINITY Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Hemophilia B

Login for BuyandBill.com Analytics

Unlock deeper insights with BuyandBill’s Comparative Report!

  • Compare ASP, WAC, and AWP across drugs.
  • Visualize Drug Price Movement Over Time
  • Tailor reports to drug class, manufacturer, or HCPCS Code.
  • Compare Biosimilar and 505(b)(2) products.

Frequently Asked Questions

Is there an available Ixinity billing and coding guide?
We have not yet identified a manufacturer source of Ixinity billing and coding information.
Are there any available Ixinity patient assistance programs?
IXINITY patient assistance information can be found through Aptevo Biotherapeutics, Llc. Visit Here →
Where can I find Ixinity prescribing information?
IXINITY prescribing information can be found at the link below: Visit Here →
Where can I find Ixinity side effect information?
Our team has not yet identified a source of side effects information for IXINITY. Please check back in a few weeks.
Does billing IXINITY require JZ/JW wastage modifiers?
CMS has identified IXINITY(J7213) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. See CMS guidelines on use of the JZ and JW wastage modifiers below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.